These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27128435)

  • 21. Quantification of collagen and elastic fibers using whole-slide images of liver biopsy specimens.
    Abe T; Hashiguchi A; Yamazaki K; Ebinuma H; Saito H; Kumada H; Izumi N; Masaki N; Sakamoto M
    Pathol Int; 2013 Jun; 63(6):305-10. PubMed ID: 23782332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.
    Ascha MS; Hanouneh IA; Lopez R; Tamimi TA; Feldstein AF; Zein NN
    Hepatology; 2010 Jun; 51(6):1972-8. PubMed ID: 20209604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High expression of CD34-positive sinusoidal endothelial cells is a risk factor for hepatocellular carcinoma in patients with HCV-associated chronic liver diseases.
    Ohmori S; Shiraki K; Sugimoto K; Sakai T; Fujikawa K; Wagayama H; Takase K; Nakano T
    Hum Pathol; 2001 Dec; 32(12):1363-70. PubMed ID: 11774170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High serum alanine aminotransferase levels for the first three successive years can predict very high incidence of hepatocellular carcinoma in patients with Child Stage A HCV-associated liver cirrhosis.
    Miyakawa K; Tarao K; Ohshige K; Morinaga S; Ohkawa S; Okamoto N; Shibuya A; Adachi S; Miura Y; Fujiyama S; Miyase S; Tomita K
    Scand J Gastroenterol; 2009; 44(11):1340-8. PubMed ID: 19891585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis.
    Sorrentino P; D'Angelo S; Ferbo U; Micheli P; Bracigliano A; Vecchione R
    J Hepatol; 2009 Feb; 50(2):351-7. PubMed ID: 19070395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
    Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L
    Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis.
    Lin CW; Lin CC; Mo LR; Chang CY; Perng DS; Hsu CC; Lo GH; Chen YS; Yen YC; Hu JT; Yu ML; Lee PH; Lin JT; Yang SS
    J Hepatol; 2013 Apr; 58(4):730-5. PubMed ID: 23220252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors of hepatocellular carcinoma development in non-cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection.
    Toyoda H; Kumada T; Tada T; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Ito T
    J Gastroenterol Hepatol; 2015 Jul; 30(7):1183-9. PubMed ID: 25678094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosis.
    Aizawa Y; Shibamoto Y; Takagi I; Zeniya M; Toda G
    Cancer; 2000 Jul; 89(1):53-9. PubMed ID: 10897000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
    Pekow JR; Bhan AK; Zheng H; Chung RT
    Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of hepatocellular carcinoma development by plasma ADAMTS13 in chronic hepatitis B and C.
    Ikeda H; Tateishi R; Enooku K; Yoshida H; Nakagawa H; Masuzaki R; Kondo Y; Goto T; Shiina S; Kume Y; Tomiya T; Inoue Y; Nishikawa T; Ohtomo N; Tanoue Y; Ono T; Koike K; Yatomi Y
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2204-11. PubMed ID: 21876190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced organic anion transporter expression is a risk factor for hepatocellular carcinoma in chronic hepatitis C patients: a propensity score matching study.
    Yasui Y; Kudo A; Kurosaki M; Matsuda S; Muraoka M; Tamaki N; Suzuki S; Hosokawa T; Ueda K; Matsunaga K; Nakanishi H; Tsuchiya K; Itakura J; Takahashi Y; Tanaka S; Asahina Y; Enomoto N; Arii S; Izumi N
    Oncology; 2014; 86(1):53-62. PubMed ID: 24401597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin.
    Ng KJ; Tseng CW; Chang TT; Tzeng SJ; Hsieh YH; Hung TH; Huang HT; Wu SF; Tseng KC
    Clin Interv Aging; 2016; 11():1035-41. PubMed ID: 27536084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Values Predict the Development of Hepatocellular Carcinoma among Patients with Chronic Hepatitis C after Sustained Virological Response.
    Sasaki R; Yamasaki K; Abiru S; Komori A; Nagaoka S; Saeki A; Hashimoto S; Bekki S; Kugiyama Y; Kuno A; Korenaga M; Togayachi A; Ocho M; Mizokami M; Narimatsu H; Ichikawa T; Nakao K; Yatsuhashi H
    PLoS One; 2015; 10(6):e0129053. PubMed ID: 26070204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive factors of risk of hepatocellular carcinoma in chronic hepatitis C.
    Gavilán JC; Ojeda G; Arnedo R; Puerta S
    Eur J Intern Med; 2013 Dec; 24(8):846-51. PubMed ID: 23849588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma.
    Matsuzaki K; Murata M; Yoshida K; Sekimoto G; Uemura Y; Sakaida N; Kaibori M; Kamiyama Y; Nishizawa M; Fujisawa J; Okazaki K; Seki T
    Hepatology; 2007 Jul; 46(1):48-57. PubMed ID: 17596875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocellular carcinoma: an emerging problem with hepatitis C.
    Jeffers L
    J Natl Med Assoc; 2000 Aug; 92(8):369-71. PubMed ID: 10992680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SEN virus infection influences the pathological findings in liver but does not affect the incidence of hepatocellular carcinoma in patients with chronic hepatitis C and liver cirrhosis.
    Moriyama M; Mikuni M; Matsumura H; Nakamura H; Oshiro S; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Tanaka N; Arakawa Y
    Liver Int; 2005 Apr; 25(2):226-35. PubMed ID: 15780043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients.
    Toyoda H; Kumada T; Kaneoka Y; Murakami Y
    J Hepatol; 2008 Jan; 48(1):43-50. PubMed ID: 18023912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.